These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12544854)

  • 1. Neurofibromatosis 2.
    Baser ME; R Evans DG; Gutmann DH
    Curr Opin Neurol; 2003 Feb; 16(1):27-33. PubMed ID: 12544854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
    Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
    Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF2: the wizardry of merlin.
    Xiao GH; Chernoff J; Testa JR
    Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role and regulatory mechanism of IL-1β on the methylation of the NF2 gene in benign meningiomas and leptomeninges.
    Wang B; Cui Z; Zhong Z; Sun Y; Yang GY; Sun Q; Bian L
    Mol Carcinog; 2016 Dec; 55(12):2268-2277. PubMed ID: 26840621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.
    Bachir S; Shah S; Shapiro S; Koehler A; Mahammedi A; Samy RN; Zuccarello M; Schorry E; Sengupta S
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas.
    Kimura Y; Saya H; Nakao M
    Neuropathology; 2000 Sep; 20(3):153-60. PubMed ID: 11132929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the treatment of neurofibromatosis-associated tumours.
    Lin AL; Gutmann DH
    Nat Rev Clin Oncol; 2013 Nov; 10(11):616-24. PubMed ID: 23939548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurofibromatosis type 2 (NF2)].
    Araki N; Takeshima H; Saya H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer.
    Ikeda K; Saeki Y; Gonzalez-Agosti C; Ramesh V; Chiocca EA
    J Neurosurg; 1999 Jul; 91(1):85-92. PubMed ID: 10389885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of neurofibromatosis type 2 gene transcripts in meningiomas supports the concept of distinct molecular variants.
    Wellenreuther R; Waha A; Vogel Y; Lenartz D; Schramm J; Wiestler OD; von Deimling A
    Lab Invest; 1997 Dec; 77(6):601-6. PubMed ID: 9426397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biology of vestibular schwannomas.
    Chang LS; Welling DB
    Methods Mol Biol; 2009; 493():163-77. PubMed ID: 18839347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple meningiomas: differential involvement of the NF2 gene in children and adults.
    Evans DG; Watson C; King A; Wallace AJ; Baser ME
    J Med Genet; 2005 Jan; 42(1):45-8. PubMed ID: 15635074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibromatosis type 2: molecular and clinical analyses in Argentine sporadic and familial cases.
    Ferrer M; Schulze A; Gonzalez S; Ferreiro V; Ciavarelli P; Otero J; Giliberto F; Basso A; Szijan I
    Neurosci Lett; 2010 Aug; 480(1):49-54. PubMed ID: 20553997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset.
    Smith MJ; Higgs JE; Bowers NL; Halliday D; Paterson J; Gillespie J; Huson SM; Freeman SR; Lloyd S; Rutherford SA; King AT; Wallace AJ; Ramsden RT; Evans DG
    J Med Genet; 2011 Apr; 48(4):261-5. PubMed ID: 21278391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromatosis type 2.
    Slattery WH
    Otolaryngol Clin North Am; 2015 Jun; 48(3):443-60. PubMed ID: 26043141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of NF2 gene product merlin in arachnoid villi and meningiomas.
    Sakuda K; Kohda Y; Matsumoto T; Park C; Seto A; Tohma Y; Hasegawa M; Kida S; Nitta H; Yamashima T; Yamashita J
    Noshuyo Byori; 1996 Nov; 13(2):145-8. PubMed ID: 8958521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced expression of schwannomin/merlin in human sporadic meningiomas.
    Lee JH; Sundaram V; Stein DJ; Kinney SE; Stacey DW; Golubić M
    Neurosurgery; 1997 Mar; 40(3):578-87. PubMed ID: 9055299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitor.
    Hirokawa Y; Tikoo A; Huynh J; Utermark T; Hanemann CO; Giovannini M; Xiao GH; Testa JR; Wood J; Maruta H
    Cancer J; 2004; 10(1):20-6. PubMed ID: 15000491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular biology of vestibular schwannomas: dissecting the pathogenic process at the molecular level.
    Neff BA; Welling DB; Akhmametyeva E; Chang LS
    Otol Neurotol; 2006 Feb; 27(2):197-208. PubMed ID: 16436990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation.
    Peyre M; Stemmer-Rachamimov A; Clermont-Taranchon E; Quentin S; El-Taraya N; Walczak C; Volk A; Niwa-Kawakita M; Karboul N; Giovannini M; Kalamarides M
    Oncogene; 2013 Sep; 32(36):4264-72. PubMed ID: 23045274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.